Lv2
104 积分 2023-07-03 加入
Single-cell immune aging clocks reveal inter-individual heterogeneity during infection and vaccination
29天前
已完结
Mechanisms and Strategies of Immunosenescence Effects on Non-Small Cell Lung Cancer (NSCLC) Treatment: A Comprehensive Analysis and Future Directions
3个月前
已完结
EP.13A.01 Preliminary Efficacy and Safety of Adebrelimab Plus Famitinib as Later-line Treatment for Extensive-Stage Small Cell Lung Cancer: A Phase 2 Trial
3个月前
已关闭
Phase 1 study of AMG 119, a chimeric antigen receptor (CAR) T cell therapy targeting DLL3, in patients with relapsed/refractory small cell lung cancer (SCLC)
3个月前
已关闭
A randomized study of etoposide and carboplatin with or without paclitaxel in the treatment of small cell lung cancer
3个月前
已关闭
Carboplatin and Paclitaxel Plus ASA404 as First-Line Chemotherapy for Extensive-Stage Small-Cell Lung Cancer: A Multicenter Single Arm Phase II Trial (SAKK 15/08)
3个月前
已完结
A Randomized, Placebo-Controlled, Phase 1b/2 Study of Rilotumumab or Ganitumab in Combination With Platinum-Based Chemotherapy as First-Line Treatment for Extensive-Stage Small-Cell Lung Cancer
3个月前
已完结
Immunosenescence and inflammaging in the aging process: age-related diseases or longevity?
4个月前
已完结
The changing treatment landscape of EGFR-mutant non-small-cell lung cancer
4个月前
已完结
Amivantamab plus Lazertinib in Previously Untreated EGFR -Mutated Advanced NSCLC
4个月前
已完结
皖公网安备34019202002308
